Biogen Idec

This is the limited version of the Biogen Idec company profile: Join LinkedIn or Sign In to see more information.

Current Company Logo

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion.

Specialties

Tysabri, Avonex, Rituxan

Your Connections to Biogen Idec

To see how you’re connected: Join Now or Sign In

New Hires and Recent Promotions at Biogen Idec

  • John Lamoureux, Director, Infrastructure Solution Design

    was Director, Network Services - this month

  • Glenn Penna, Associate Director, IT PMO

    was IT Program Manager - this month

  • Amin Abujoub, Director Global Clinical Drug Supply

    was Director CMC Program Management - last month

  • Rachael Asselin, Associate Director, HealthCare Systems Marketing

    was Sr Manager, Managed Care Marketing - 2 months ago

  • Bruce Madsen, Sr. Manager, QC

    was Sr. Manager QC Microbiology - 3 months ago

To see more new hires & promotions: Join Now or Sign In

Jobs at Biogen Idec

Job Title Location Hiring Manager
Associate Director, Medical Affairs Zürich Area, Switzerland

To see who posted this job and how you’re connected: Join LinkedIn or Sign In

Last edited by Sr. Corporate Recruiter at Biogen Idec

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Biogen Idec. This page is not endorsed by or affiliated with Biogen Idec. For questions regarding LinkedIn Company Profiles, contact us.

Biogen Idec (BIIB) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions